Gynecology outpatients receiving telephone consultations (TCs) mostly describe their experience as good or very good, with positive themes including convenience and effectiveness, according to a study published online May 25 in BJOG.
AbbVie announced upadacitinib (15 mg and 30 mg, once daily) plus topical corticosteroids (TCS) met the co-primary endpoints and all secondary endpoints in AD Up, the third pivotal Phase 3 study of RINVOQ in atopic dermatitis.
There has been a large number of studies exploring the possible toxic effects of TCS on living things. The article provides some help for common health management.